Selligence

Liquidia Technologies

Company Information

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.


Industries:
Information Technology
Science and Engineering
Biotechnology
Technology, Hardware and Equipment
Government and Military
Manufacturing
Industrial
Corporate Supplies and Printing
Aerospace and Defence
Electrical Engineering
Pharmaceuticals and Life Sciences
Health Care
Locations:
Morrisville
New York, Ny
Boston, Ma
Rochester, Ny
Washington, Dc
Summit, Nj
Nashville, Tn
Atlanta, Ga
Indianapolis, In
Cleveland, Oh
Birmingham, Al
Chicago, Il
Columbus, Oh
Milwaukee, Wi
Denver, Co
San Jose, Ca
Oklahoma City, Ok
Raleigh, Nc
Philadelphia, Pa
Charlotte, Nc
Tampa, Fl
Orlando, Fl
Jacksonville, Fl
Louisville, Ky
Omaha, Ne
Allentown, Pa
Richmond, Va
San Antonio, Tx
Dallas, Tx
Salt Lake City, Ut
Seattle, Wa
San Francisco, Ca
Phoenix, Az
Miami, Fl
Sarasota, Fl
Grand Rapids, Mi
Pittsburgh, Pa
Minneapolis, Mn
Houston, Tx
Detroit, Mi
New Orleans, La
Tucson
Little Rock, Ar
Los Angeles, Ca
San Diego, Ca
St. Louis
Morrisville
crunchbase:http://www.crunchbase.com/organization/liquidia-technologies
twitter:http://www.twitter.com/liquidia_inc
facebook:http://www.facebook.com/liquidia-technologies-inc/25300608
linkedin:https://www.linkedin.com/company/liquidia-technologies
homepage:https://liquidia.com
Emailinfo@liquidia.com
Description:
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
Stock Code:NASDAQ:LQDA

Employees

Number of employees
51-200

Trends

Last 4 weeks

Last 3 months
DivestingInvesting

Recent Events

News
Job Posting
Other News
See All news